Abstract
No public abstract is available from the verified source records.
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Endoscopic gastric remodeling and its histologic impact on metabolic dysfunction–associated steatohepatitis: a 12-month prospective study
10.1016/j.gie.2026.02.042 · 2026
Endoscopic gastric remodeling and its histologic impact on metabolic dysfunction–associated steatohepatitis: a 12-month prospective study
10.1016/j.gie.2026.02.042 · 2026
The role of endoscopic therapies for patients with metabolic dysfunction-associated steatotic liver disease (MASLD)
10.1080/17474124.2026.2632873 · 2026
The role of endoscopic therapies for patients with metabolic dysfunction-associated steatotic liver disease (MASLD)
10.1080/17474124.2026.2632873 · 2026
Liver biopsy in metabolic-associated steatotic liver disease: accuracy, challenges, and alternatives
2026
Liver biopsy in metabolic-associated steatotic liver disease: accuracy, challenges, and alternatives
2026
Combination therapy of endoscopic gastric remodeling with GLP-1RA for the treatment of MASLD
10.1007/s11695-024-07178-5 · 2024
Combination therapy of endoscopic gastric remodeling with GLP-1RA for the treatment of MASLD
10.1007/s11695-024-07178-5 · 2024
No additional external references are available.